WHO recommends ARVs to prevent HIV in men who have sex with men
The World Health Organisation’s (WHO) new guidelines are aimed at stemming new HIV infections in five high risk groups, including MSM, injecting drug users, prisoners and sex workers.
The WHO recommends that HIV-negative MSM be offered either the ARV tenofovir, or a fixed dose combination of tenofovir and emtricitabine to prevent HIV infection, alongside condoms.
Often known by the brand name Truvada, a combination of tenofovir and emtricitabine is already included in South Africa’s ARV tender to treat HIV. It is not however yet registered for use to prevent HIV.
According to the WHO, the inability to negotiate safe sex and high levels of stigma are just some of the factors putting these groups at a higher risk of contracting the virus.
Globally, about half of all new HIV infections occur among at risk populations, which also include transgender people, or people who do not identify with the sexuality they were born with.
[quote float=”right”]Truvada is not registered in South Africa for HIV prevention, which precludes the Department of Health from rolling it out
Cape Town’s Dr Kevin Rebe was one of several South Africans that helped develop the new WHO guidelines. Rebe works with the Anova Health Institute’s Health4Men project, which runs MSM-friendly clinics in Johannesburg and Khayelitsha.
“Truvada is not registered in South Africa for the indication of HIV prevention – only for HIV treatment,” Rebe told Health-e News. “This precludes the Department of Health rolling out Truvada (to prevent HIV infection).”
“Registration needs to occur as a matter of urgency,” said Rebe who added that until that happens, the country’s conditional ARV grant will not fund the use of ARVs for prevention outside prevention of mother-to-child transmission programmes.
At about R90 per 28-pills, Truvada is on par with the country’s three-in-one ARV, according to Medicines Sans Frontieres’ Access Campaign Advocacy Officer Julia Hill.
The WHO’s latest guidelines also continue to recommend daily doses of Truvada for HIV-negative people with stable HIV-positive partners but doctors caution that anyone taking Truvada to prevent HIV infection will have to be regularly monitored. People who contract HIV should be switched to a triple combination of ARVs to avoid developing resistance.
New WHO guidelines also now recommend that people who are likely to witness morphine or heroin overdoses – including fellow drug users – should be trained to administer life-saving naloxone injections in case of overdoses.
As of late last year. no such programmes are available in South Africa, according to Bronwyn Myers, chief specialist scientist at the Medical Research Council’s Alcohol and Drug Unit. – Health-e News Service.
Edited versions of this article first appeared in the 12 July editions of the Saturday Star and Weekend Argus.
Author
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
WHO recommends ARVs to prevent HIV in men who have sex with men
by lauralopez, Health-e News
July 14, 2014